Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

This grant supports clinical trials and research to improve pain management, addiction treatment, anesthesia safety, and drug prescribing practices.

HHS-FDA$2,000,000Forecasted

Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

NIDA plans to fund research developing interventions to prevent and treat substance use disorders and overdoses, from preclinical studies to clinical trials.

HHS-NIH11Due Feb 22, 2027$15,000,000

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Use existing data to analyze drug use behaviors, prevention strategies, and service utilization, aiming to advance substance use research.

HHS-NIH11Due Nov 3, 2026· 7d

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Funds basic research on the harmful acute and delayed effects of ultra-potent synthetic opioids like fentanyl, including combinations, to develop countermeasures.

HHS-NIH11Due Nov 18, 2026$1,500,000

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Funding for research developing non-addictive pain treatments through early drug discovery to support the Pain Therapeutics Development Program.

HHS-NIH11Due Dec 16, 2026$350,000